Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inavac (Vaksin Merah Putih) Phase III Immunobridging Study
NCT05508477Phase 3Unknown
- Sponsor
- Dr. Soetomo General Hospital
- Start
- Jun 2022
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
A Phase 3 trial of INAVAC in coronavirus disease 2019 (COVID-19), sponsored by Dr. Soetomo General Hospital. Status: unknown.
02
Drugs
INAVAC
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05508477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05508477.